Intra-Cellular Therapies Inc. (ITCI) |
|
13.71 -0.38 (-2.7%)
|
06-20 09:46 |
|
Open: |
14.31 |
Pre. Close: |
14.09 |
|
High:
|
14.34 |
Low:
|
13.68 |
|
Volume:
|
80,470 |
Market Cap:
|
756M |
|
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
14.303 - 14.373 |
14.373 - 14.432 |
|
Low:
|
13.537 - 13.616 |
13.616 - 13.684 |
|
Close:
|
13.971 - 14.094 |
14.094 - 14.201 |
|
Technical analysis |
as of: 2019-06-19 4:32:03 PM |
|
Overall:
|
 |
| Stoxline posted a BUY today, same as yesterday. Upward movement continues. |
| Target: |
Six months: 16.83 One year: 19.66 |
| Support: |
Support1: 11.89 Support2: 10.34 |
| Resistance: |
Resistance1: 14.41 Resistance2: 16.83 |
| Pivot: |
12.43  |
| Moving Average: |
MA(5): 13.50 MA(20): 12.61
MA(100): 12.85 MA(250): 15.83  |
| MACD: |
MACD(12,26): 0.16 Signal(9): -0.12 |
| Stochastic oscillator: |
%K(14,3): 91.62 %D(3): 84.06 |
| RSI: |
RSI(14): 61.29 |
| 52-week: |
High: 23.62 Low: 10.21 Change(%): -28.2 |
| Average Vol(K): |
3-Month: 36495 10-Days: 60372 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.ITCI has closed below upper band by 10.5%. Bollinger Bands are 92.6% wider than normal. The large width of the bands suggest high volatility as compared to ITCI's normal range. The bands have been in this wide range for 6 bars. This is a sign that the current trend might continue. |
|
|
Headline News |
Mon, 17 Jun 2019 16:29:32 Z
Monday 6/17 Insider Buying Report: ITCI, CNR
Wed, 08 May 2019 21:55:18 Z
Uber: Pre-IPO Observations On Performance
Wed, 08 May 2019 19:26:49 Z
Intra-Cellular Therapies, Inc. (ITCI) Q1 2019 Earnings Call Transcript
Thu, 21 Mar 2019 21:08:23 Z
Notable Thursday Option Activity: CLW, GPRE, ITCI
Wed, 27 Feb 2019 18:11:25 Z
Intra-Cellular Therapies Inc (ITCI) Q4 2018 Earnings Conference Call Transcript
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
|
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. (M) |
55.13 |
| Shares Float (M) |
52.65 |
|
% Held by Insiders
|
|
|
% Held by Institutions
|
|
|
Shares Short (K)
|
|
|
Shares Short P. Month (K)
|
|
Stock Financials |
|
EPS
|
-2.840 |
|
EPS Est. Current Year
|
-2.340 |
|
EPS Est. Next Year
|
-2.810 |
|
EPS Est. Next Quarter
|
-0.690 |
|
Forward EPS
|
-3.041 |
|
Book Value (p.s.)
|
2.150 |
|
PEG Ratio
|
|
|
Profit Margin
|
|
|
Operating Margin
|
|
|
Return on Assets (ttm)
|
-41.3 |
|
Return on Equity (ttm)
|
-45.8 |
|
Qtrly Rev. Growth
|
|
|
Gross Profit (p.s.)
|
|
|
Sales Per Share
|
|
|
EBITDA (p.s.)
|
|
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
-126.81 |
|
Levered Free Cash Flow (M)
|
-73.78 |
Stock Valuations |
|
P/E
|
-4.96 |
|
P/E Growth Ratio
|
0.01 |
|
P/BV
|
6.55 |
|
P/S
|
|
|
P/CF
|
-6.13 |
Dividends & Splits |
|
Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Forward Dividend
|
|
|
Last Split Date
|
|
|
Last Split Ratio
|
-1e+010 |
|
7 Binary Options
|
|
Your Ad Here
|
|
